The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

56 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs) as human immunodeficiency virus type 1 integrase inhibitors: Influence of the alkylcarboxamide substitution of position 4.EBI
University of Lille
Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.EBI
University of Lille
Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis.EBI
University of Lille
Synthesis and pharmacological evaluation of benzannulated derivatives as potent and selective sigma-1 protein ligands.EBI
University of Lille
Carboline- and phenothiazine-derivated heterocycles as potent SIGMA-1 protein ligands.EBI
University of Lille
Investigation of a novel series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as human immunodeficiency virus type 1 integrase inhibitors.EBI
University of Lille
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-ß hydrolysis.EBI
University of Lille
Switching cannabinoid response from CB(2) agonists to FAAH inhibitors.EBI
University of Lille
Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group.EBI
University of Lille
New selective carbonic anhydrase IX inhibitors: synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides.EBI
University of Lille
Design, synthesis and in vitro antimalarial activity of an acylhydrazone library.EBI
University of Lille
Synthesis and in vitro and in vivo antimalarial activity of N1-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine derivatives.EBI
University of Lille
Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis.EBI
University of Lille
Synthesis and antimalarial evaluation of new 1,4-bis(3-aminopropyl)piperazine derivatives.EBI
University of Lille
Structure-activity relationships and blood distribution of antiplasmodial aminopeptidase-1 inhibitors.EBI
University of Lille
4-Oxo-1,4-dihydropyridines as selective CB2 cannabinoid receptor ligands. Part 2: discovery of new agonists endowed with protective effect against experimental colitis.EBI
University of Lille
Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis.EBI
University of Lille
Drug-to-genome-to-drug, step 2: reversing selectivity in a series of antiplasmodial compounds.EBI
University of Lille
Synthesis and structure-activity relationships of (aryloxy)quinazoline ureas as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors.EBI
University of Lille
Design, synthesis and pharmacological evaluation of novel naphthalenic derivatives as selective MT(1) melatoninergic ligands.EBI
University of Lille
Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.EBI
University of Lille
Design, synthesis, and pharmacological evaluation of new farnesyl protein transferase inhibitors.EBI
University of Lille
Design, synthesis and antimalarial activity of novel, quinoline-based, zinc metallo-aminopeptidase inhibitors.EBI
University of Lille
Design, synthesis and pharmacological evaluation of new series of naphthalenic analogues as melatoninergic (MT1/MT2) and serotoninergic 5-HT2C dual ligands (I).EBI
University of Lille
Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors.EBI
University of Lille
Application of Ullmann and Ullmann-Finkelstein reactions for the synthesis of N-aryl-N-(1H-pyrazol-3-yl) acetamide or N-(1-aryl-1H-pyrazol-3-yl) acetamide derivatives and pharmacological evaluation.EBI
University of Lille
New FAAH inhibitors based on 3-carboxamido-5-aryl-isoxazole scaffold that protect against experimental colitis.EBI
University of Lille
Preparation and pharmacological evaluation of a novel series of 2-(phenylthio)benzo[b]thiophenes as selective MT2 receptor ligands.EBI
University of Lille
Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors.EBI
University of Lille
Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.EBI
University of Lille
Impact of aryloxy-linked quinazolines: a novel series of selective VEGFR-2 receptor tyrosine kinase inhibitors.EBI
University of Lille
Design, solid-phase synthesis, and biological evaluation of novel 1,5-diarylpyrrole-3-carboxamides as carbonic anhydrase IX inhibitors.EBI
University of Lille
New non-hydroxamic ADAMTS-5 inhibitors based on the 1,2,4-triazole-3-thiol scaffold.EBI
University of Lille
Sigma-1 ligands: Tic-hydantoin as a key pharmacophore.EBI
University of Lille
Novel non-carboxylic acid retinoids: 1,2,4-oxadiazol-5-one derivatives.EBI
University of Lille
Synthesis of a 200-member library of squaric acid N-hydroxylamide amides.EBI
University of Lille
Receptor Interacting Ser/Thr-Protein Kinase 2 as a New Therapeutic Target.EBI
University of Lille
Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents.EBI
University of Lille
Pyroglutamide-Based P2X7 Receptor Antagonists Targeting Inflammatory Bowel Disease.EBI
University of Lille
Identification of novel quinazoline derivatives as potent antiplasmodial agents.EBI
University of Lille
Design and synthesis of fused tetrahydroisoquinoline-iminoimidazolines.EBI
University of Lille
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis.EBI
University of Lille
4-Substituted 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as a Novel Class of HIV-1 Integrase Inhibitors.EBI
University of Lille
Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity.EBI
University of Lille
Synthesis and biological evaluation of phenstatin metabolites.EBI
University of Lille
2-hydroxyisoquinoline-1,3(2H,4H)-diones as inhibitors of HIV-1 integrase and reverse transcriptase RNase H domain: influence of the alkylation of position 4.EBI
University of Lille
Synthesis, biological evaluation and docking studies of 4-amino-tetrahydroquinazolino[3,2-e]purine derivatives.EBI
University of Lille
The total synthesis of fukiic acid, an HIV-1 integrase inhibitor.EBI
University of Lille
Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.EBI
University of Lille
Synthesis and biological activities of a series of 4,5-diaryl-3-hydroxy-2(5H)-furanones.EBI
University of Lille
Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents.EBI
University of Lille
Design, synthesis and biological evaluation of substituted dioxodibenzothiazepines and dibenzocycloheptanes as farnesyltransferase inhibitors.EBI
University of Lille
A phenotypic approach to the discovery of compounds that promote non-amyloidogenic processing of the amyloid precursor protein: Toward a new profile of indirect β-secretase inhibitors.EBI
University of Lille
New phenylaniline derivatives as modulators of amyloid protein precursor metabolism.EBI
University of Lille
Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors.EBI
University of Lille
Anti-diabetic activity of fused PPARγ-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expression.EBI
University of Lille